The company expects 2025 adjusted profit to be in the range of $8.15 to $8.35 per share, compared with the average of ...
Zimmer Biomet to acquire Paragon 28 for $13/share, totaling $1.2B in enterprise value. Deal expected to close in H1 2025, with potential $1/share CVR based on 2026 sales milestones. Brand New ...
In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Zimmer Biomet Holdings (ZBH – Research Report), with a price ...
Truist analyst Richard Newitter lowered the firm’s price target on Zimmer Biomet (ZBH) to $113 from $118 and keeps a Hold rating on the shares.
Zimmer Biomet (NYSE: ZBH) shares dipped slightly today on fourth-quarter results that came in just ahead of the consensus ...
When shares of Zimmer Biomet (NYSE:ZBH) moved down to the $105 mark in September, I believed that real value was showing up. Shares sold off despite the projection of mid-single digit sales growth ...
Zimmer Biomet posted fourth-quarter revenue growth of 5% in constant currency, which is generally consistent with the preceding quarters in 2024. Why it matters: As Zimmer Biomet has pursued a ...
Zimmer Biomet announced plans to acquire medical device company Paragon 28 for $1.1 billion, enhancing its range of ...
Recently, Zimmer Biomet agreed to acquire Paragon 28, Inc. FNA for an upfront cash payment of $13.00 per share, corresponding to an equity value of approximately $1.1 billion and an enterprise value ...
Medical device company Zimmer Biomet (NYSE:ZBH) will be reporting earnings tomorrow before market hours. Here’s what investors should know. Zimmer Biomet beat analysts’ revenue expectations by ...
On Tuesday, the company inked a deal to be acquired by Zimmer Biomet Holdings, Inc. (NYSE:ZBH) at around $1.1 billion in equity and $1.2 billion in enterprise value. Zimmer Biomet plans to ...
On Thursday, Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported fourth-quarter adjusted EPS of $2.31, up from $2.20 a year ago, beating the Street estimates of $2.30. The orthopedic giant reported ...